LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Aktien・Gossamer Bio Inc

Search

Gossamer Bio Inc

Geschlossen

BrancheGesundheitswesen

0.15

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.13

Max

0.16

Schlüsselkennzahlen
By Trading Economics
Einkommen	574K -47M
Verkäufe	3.2M 17M
EPS	-0.2
Gewinnspanne	-275.223
Angestellte	161
EBITDA	1.2M -45M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+3225% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	3. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-38M 41M
Vorheriger Eröffnungskurs	0.15
Vorheriger Schlusskurs	0.15

Gossamer Bio Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juni 2026, 23:36 UTC

Ergebnisse

Correction to Oracle Reports Higher 4Q Profit Article

10. Juni 2026, 23:19 UTC

Heiße Aktien

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10. Juni 2026, 23:09 UTC

Wichtige Markttreiber

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10. Juni 2026, 23:04 UTC

Ergebnisse

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10. Juni 2026, 20:44 UTC

Wichtige Markttreiber

Caterpillar Raises Quarterly Dividend 8%

10. Juni 2026, 23:49 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Should Take No Options Off The Table

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10. Juni 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10. Juni 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10. Juni 2026, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10. Juni 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10. Juni 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10. Juni 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10. Juni 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10. Juni 2026, 21:57 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:52 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:35 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:22 UTC

Ergebnisse

Oracle Stock Slides on Increased Capital Spending -- WSJ

10. Juni 2026, 20:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Juni 2026, 20:39 UTC

Market Talk

Ergebnisse

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10. Juni 2026, 20:34 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 20:33 UTC

Ergebnisse

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Peer-Vergleich

Kursveränderung

Gossamer Bio Inc Prognose

Kursziel

By TipRanks

3225% Vorteil

12-Monats-Prognose

Durchschnitt 5.32 USD 3225%

Hoch 15 USD

Tief 0.28 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Gossamer Bio Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

2

Buy

3

Halten

1

Sell

Basierend auf 6 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Gossamer Bio Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,136.41

JNJ

Johnson and Johnson

238.85

ABBV

AbbVie Inc

225.29

UNH

UnitedHealth Group Inc

407.06

MRK

Merck & Co Inc.

119

Live chat